Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Avalo Therapeutics Inc’s current trading price is -48.75% away from its 52-week high, while its distance from the 52-week low is 141.89%. The stock’s price range over this period has fluctuated between $3.39 and $16.00. The company, operating within the financial sector, had a trading volume of approximately 1.55 million for the day, which was noticeably higher than the average daily share volume of 0.11 million over the last 3 months.
At present, Avalo Therapeutics Inc (AVTX) has a stock price of $8.2. In the previous session, the stock saw a rise, peaking at $48.0 after an opening price of $8.2. The day’s lowest price was $15.0, and it closed at $8.97.
In terms of market performance, Avalo Therapeutics Inc had a fairly even.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Avalo Therapeutics Inc (AVTX) has experienced a quarterly rise of 63.35% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 88.78M and boasts a workforce of 23 employees.
Avalo Therapeutics Inc: What Analysts Are Saying
As of right now, 5 analysts are rating Avalo Therapeutics Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.45, with a change in price of +0.50. Similarly, Avalo Therapeutics Inc recorded 107,418 in trading volume during the last 100 days, posting a change of +6.49%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for AVTX stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.02.
AVTX Stock Stochastic Average
Today’s raw stochastic average for Avalo Therapeutics Inc over the last 50 days is 79.77%.This indicates a increase from the raw stochastic average of the past 20 days, which was 74.79%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 81.60% and 85.61%, respectively.
AVTX Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -25.79%.However, over the last six months, we can see a weaker performance of 2.24%. Over the last 30 days, the price of AVTX has fallen by 72.63%. And in the last five days, it has surged by 25.38%.
